XML 33 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
 9 Months Ended
Dec. 31, 2014
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

2.             EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

 

Earnings (Loss) Per Share

 

A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):

 

                                                                                                                                                                                    

 

 

For the quarter ended
December 31

 

For the nine months ended
December 31

 

 

 

2014

 

2013

 

2014

 

2013

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations

 

$
4,474

 

$
14,578

 

$
(3,094

)

$
36,519

 

Net earnings (loss) from discontinued operations

 
(318

)
489

 
(1,898

)
1,507

 

Net earnings (loss)

 

$
4,156

 

$
15,067

 

$
(4,992

)

$
38,026

 

Net loss attributable to noncontrolling interest

 

—

 

—

 

—

 
(60

)

Net earnings (loss) attributable to Acxiom

 

$
4,156

 

$
15,067

 

$
(4,992

)

$
38,086

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 
77,039

 
75,009

 
76,998

 
74,155

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$
0.06

 

$
0.19

 

$
(0.04

)

$
0.49

 

Discontinued operations

 

$

—

 

$
0.01

 

$
(0.02

)

$
0.02

 

Net earnings (loss)

 

$
0.05

 

$
0.20

 

$
(0.06

)

$
0.51

 

Net loss attributable to noncontrolling interest

 

$

—

 

$

—

 

$

—

 

$

—

 

Net earnings (loss) attributable to Acxiom

 

$
0.05

 

$
0.20

 

$
(0.06

)

$
0.51

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 
77,039

 
75,009

 
76,998

 
74,155

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 
1,263

 
2,830

 

—

 
2,301

 

Diluted weighted-average shares outstanding

 
78,302

 
77,839

 
76,998

 
76,456

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$
0.06

 

$
0.19

 

$
(0.04

)

$
0.48

 

Discontinued operations

 

$

—

 

$
0.01

 

$
(0.02

)

$
0.02

 

Net earnings (loss)

 

$
0.05

 

$
0.19

 

$
(0.06

)

$
0.50

 

Net earnings (loss) attributable to noncontrolling interest

 

$

—

 

$

—

 

$

—

 

$

—

 

Net earnings (loss) attributable to Acxiom

 

$
0.05

 

$
0.19

 

$
(0.06

)

$
0.50

 

 

Some earnings (loss) per share amounts may not add due to rounding.

 

Options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings (loss) per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

 

                                                                                                                                                                                    

 

 

For the quarter ended
December 31

 

For the nine months ended
December 31

 

 

 

2014

 

2013

 

2014

 

2013

 

Number of shares outstanding under options, warrants and restricted stock units

 

2,012

 

549

 

1,838

 

1,400

 

Range of exercise prices for options and warrants

 

$18.78-$62.06

 

$32.85-$62.06

 

$19.18-$62.06

 

$21.46-$62.06

 

 

In addition to the antidilutive items shown above, because of the loss reported for the nine months ended December 31, 2014, all options, warrants, and restricted stock are excluded from the diluted weighted-average shares calculation for that period since the effect would be antidilutive.

 

Stockholders’ Equity

 

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded on December 5, 2011, on May 24, 2012, on February 5, 2013, on November 18, 2013, and again on November 12, 2014.  Under the modified common stock repurchase program, the Company may purchase up to $250.0 million of its common stock through the period ending November 12, 2015. During the nine months ended December 31, 2014, the Company repurchased 0.5 million shares of its common stock for $9.9 million.  Through December 31, 2014, the Company had repurchased 12.9 million shares of its stock for $202.4 million, leaving remaining capacity of $47.6 million under the stock repurchase program.

 

Accumulated Other Comprehensive Income

 

The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):

 

                                                                                                                                                                                    

 

 

December 31,
2014

 

March 31,
2014

 

Foreign currency translation

 

$
9,393

 

$
13,686

 

Unrealized loss on interest rate swap

 
(29

)
(24

)

 

 

$
9,364

 

$
13,662

 

 

Noncontrolling Interest

 

During fiscal year 2011, the Company acquired a 70% interest in GoDigital (Acxiom Brazil), a data quality and precision marketing firm located in Brazil.  Since Acxiom had voting control of the entity, its results were included in Acxiom’s consolidated results.  The interest that was not Acxiom-owned was reflected as noncontrolling interest in the condensed consolidated statement of operations and the condensed consolidated balance sheets.  During fiscal 2014, the Company acquired the balance of the outstanding equity interests it did not already own in Acxiom Brazil and, as a result, the subsidiary is now wholly-owned.